BIP Austin digital publishing platform

collapse
Home / Healthcare / Smith & Nephew Senior Regulatory Affairs Specialist

Smith & Nephew Senior Regulatory Affairs Specialist

Jul 03, 2026  Twila Rosenbaum 30 views
Smith & Nephew Senior Regulatory Affairs Specialist

Introduction to Smith & Nephew

Smith & Nephew (NYSE: SNN; LSE: SN) is a global medical technology company headquartered in London, United Kingdom, with major operational hubs in Memphis, Tennessee, and Watford, UK. Founded in 1856, the company has evolved into a £5 billion (approx. $6.3 billion) enterprise employing over 18,000 people worldwide. Smith & Nephew designs, manufactures, and markets advanced medical devices and solutions across three core segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. Its products are used by surgeons, clinicians, and healthcare institutions in more than 100 countries, making it a trusted partner in the healthcare industry.

The company is recognized as a top-tier Healthcare company by analysts and investors, consistently ranking among the world’s leading medical device firms. Smith & Nephew’s reputation stems from a relentless focus on innovation, patient outcomes, and operational excellence. Organizations ranging from large hospital networks to specialized ambulatory surgical centers rely on Smith & Nephew’s portfolio—from robotic-assisted surgery platforms like CORI Surgical System to advanced wound dressings such as ALLEVYN Life. The company’s commitment to sustainability, diversity, and ethical business practices further solidifies its position as a corporate role model within the Healthcare sector.

Smith & Nephew’s market reputation is bolstered by strong financial performance, a robust R&D pipeline, and strategic acquisitions (e.g., Osia, Blue Belt Technologies). Its products address pressing medical challenges, including osteoarthritis, tendon injuries, chronic wounds, and hearing loss. As healthcare systems evolve toward value-based care, Smith & Nephew’s integrated solutions help providers reduce costs while improving clinical outcomes. This introduction sets the stage for a deeper exploration of the company’s history, strategy, and culture—foundational knowledge for any candidate considering a career at Smith & Nephew.

Company History and Business Evolution

Smith & Nephew was founded in 1856 by Thomas James Smith in Hull, England, as a small pharmacy specializing in cod liver oil. The company’s early years focused on the production of plasters and bandages, leveraging the region’s access to raw materials. In 1890, after T.J. Smith’s death, his nephew Horatio Nelson Smith took over and expanded the product line into surgical dressings. The company formally incorporated as Smith & Nephew Limited in 1906. Key milestones include the development of the first elastic adhesive bandage in 1929, which revolutionized wound care, and the introduction of the first disposable surgical gloves in the UK during the 1950s.

Post–World War II, Smith & Nephew diversified into orthopaedics through the acquisition of Richards Manufacturing Company (1985), a U.S.–based orthopaedic implants firm. This move propelled the company into joint replacement and trauma devices. Subsequent acquisitions—such as Plus Orthopedics (2003) and Blue Belt Technologies (2016)—strengthened its position in robotic-assisted surgery and personalized implants. In wound management, the purchase of ConvaTec’s wound care business (2000) and later Osia (2020) expanded its advanced wound dressing portfolio. The company also entered sports medicine via the acquisition of Acufex (1998) and later Opus Medical (2008).

Today, Smith & Nephew operates in over 30 countries with manufacturing facilities in the UK, US, Germany, and Ireland. It has invested heavily in digital health and robotics, launching the CORI Surgical System in 2020. The evolution from a small pharmacy to a global medtech powerhouse reflects its ability to adapt, innovate, and acquire strategically. The company’s historical resilience—surviving two world wars, economic downturns, and industry disruptions—demonstrates a durable business model. Smith & Nephew’s evolution is a testament to its focus on clinical excellence and customer intimacy, which remain core tenets today.

Smith & Nephew at a Glance

  • Headquarters: London, United Kingdom (registered office) and Watford, UK (operational HQ)
  • Founded: 1856 by Thomas James Smith
  • CEO: Deepak Nath (as of 2023)
  • Revenue (2023): $5.6 billion USD
  • Employees: Over 18,000 worldwide
  • Stock Listings: NYSE (SNN) and LSE (SN)
  • Industry: Medical Devices – Orthopaedics, Sports Medicine, Wound Care
  • Key Products: CORI Surgical Robot, ALLEVYN dressings, PICO negative pressure wound therapy, JOURNEY II knee system, ANTHOLOGY hip system
  • Global Presence: Operations in 30+ countries, products in 100+
  • R&D Investment: Approximately 6% of revenue annually
  • Number of Patents: Over 5,000 granted patents
  • Regulatory Certifications: ISO 13485, FDA registered, EU MDR compliant
  • Awards: Frost & Sullivan Product Leadership, MedTech Breakthrough Awards
  • Board Size: Nine directors, including two women
  • ESG Rating: MSCI AA, S&P Global CSA top quartile
  • Manufacturing Sites: 14 facilities across the US, UK, Germany, and Ireland
  • Ecommerce Channel: Direct sales force and distributor network
  • Acquisition History: Over 20 major acquisitions since 2000
  • Clinical Trial Enrollment: Active in 50+ clinical studies
  • Market Capitalization: ~$12 billion (as of mid-2024)

Mission, Vision, and Core Corporate Values

Mission: To make a meaningful difference in people’s lives by providing innovative medical technologies that enhance patient mobility and healing. Vision: To be the world’s leading medical technology company, setting the standard for clinical outcomes, customer satisfaction, and responsible business conduct.

Smith & Nephew’s core values—Integrity, Inclusion, Innovation, and Performance—serve as the foundation for all corporate decisions. Integrity means acting ethically, transparently, and in compliance with laws. Inclusion fosters a diverse workforce where every employee feels valued and empowered. Innovation drives the continuous development of breakthrough products and processes. Performance focuses on delivering high-quality results that satisfy patients, customers, and shareholders. These values are embedded in employee training, performance metrics, and leadership evaluations.

The company also emphasizes a Patient First philosophy, ensuring that every product and service ultimately benefits the end user. This value system guides Smith & Nephew’s response to regulatory challenges, market shifts, and competitive pressures. By adhering to these principles, the company maintains trust with healthcare providers, insurers, and regulators. For employees, these values create a shared sense of purpose and a strong ethical compass.

Business Strategy and Future Roadmap

Smith & Nephew’s current business strategy, dubbed “Sustain & Strengthen,” focuses on three pillars: Operational Excellence, Portfolio Optimization, and Commercial Transformation. First, operational excellence involves streamlining manufacturing, supply chain, and quality systems to improve margins and reliability. The company has invested in automation and digital traceability across its factory network, aiming for a 200–300 basis point margin improvement by 2026.

Second, portfolio optimization means prioritizing higher-growth categories such as robotics, advanced wound care, and sports medicine while divesting non-core assets. For example, Smith & Nephew sold its hip and knee instrument businesses in 2022 to sharpen focus on core implant systems. The company continues to evaluate bolt-on acquisitions in robotics and digital surgery.

Third, commercial transformation leverages data analytics and digital marketing to enhance customer engagement. The company launched a CRM platform for sales teams and an e-learning portal for surgeons. Looking to the future, Smith & Nephew targets expansion in emerging markets (Asia-Pacific, Middle East) and the outpatient surgery trend. Its pipeline includes next-generation implants with sensor technology and an autonomous robotic suture device. The roadmap also includes achieving carbon neutrality by 2045, with interim targets for 2030. This forward-looking strategy positions Smith & Nephew for sustainable growth in a dynamic healthcare landscape.

Products, Technologies, and Services

Smith & Nephew offers a comprehensive range of products across its three business segments:

  • Orthopaedics: Joint replacement systems (knee, hip, shoulder, ankle) including JOURNEY II, ANTHOLOGY, and POLARSTEM. Trauma products (PERI-LOC locking plates) and the CORI Surgical System, a next-generation robotics platform for partial and total knee replacements.
  • Sports Medicine & ENT: Arthroscopic devices (suture anchors, shavers, cannulas) for soft tissue repair; the REGENETEN tendon repair implant; and ENT products for sinus and ear surgeries.
  • Advanced Wound Management: Negative pressure wound therapy (PICO and RENASYS), antimicrobial dressings (ALLEVYN, IV3000), and regenerative tissue matrices (OASIS, DERMAGRAFT).

Technologically, Smith & Nephew leads with robotic-assisted surgery, digital templating, and smart dressings. Its CORI robot uses CT-free navigation, reducing radiation exposure for patients. The PICO system offers disposable, single-use NPWT, improving patient mobility. The company’s 3D-printed patient-specific guides enhance surgical precision. Services include surgeon training programs (Smith & Nephew Academy), field clinical support, and a customer portal for ordering and inventory management.

Industries and Markets Served

Smith & Nephew serves the healthcare industry exclusively, with products used in hospitals, ambulatory surgery centers (ASCs), clinics, and long-term care facilities. Its primary markets are orthopaedic surgery, sports medicine, ENT, and wound care. Geographically, the largest revenue region is the United States (50%+), followed by Europe, Asia-Pacific, and Rest of World. The company addresses the needs of aging populations, active lifestyles, and chronic wounds, catering to both public and private healthcare systems.

Leadership and Management Philosophy

Under CEO Deepak Nath, Smith & Nephew’s leadership emphasizes accountability, agility, and empowerment. The executive team comprises seasoned professionals from diverse backgrounds in medtech, pharma, and consumer goods. Management philosophy centers on a “coach-style” approach, where leaders facilitate cross-functional collaboration and data-driven decision-making. Annual “town halls” and “listening sessions” ensure employee voices are heard. The company promotes internal mobility and offers leadership development programs, reflecting a culture that nurtures future leaders.

Corporate Events, Conferences, and Community Engagement

Smith & Nephew actively participates in major medical conferences such as AAOS (American Academy of Orthopaedic Surgeons), EWMA (European Wound Management Association), and AANA (Arthroscopy Association of North America). It sponsors surgical workshops and cadaver labs globally. Community engagement includes the Smith & Nephew Foundation, which funds educational initiatives in underserved communities. The company also organizes local charity runs, blood drives, and environmental clean-ups, encouraging employee volunteerism with paid time off. Such events reinforce its commitment to corporate social responsibility.

Employees and Workplace Culture

With a workforce of 18,000+, Smith & Nephew fosters a collaborative and inclusive culture. Employee resource groups (Women in MedTech, Pride, Veterans) drive DEI initiatives. The company has received top scores on the Human Rights Campaign’s Corporate Equality Index. Work-life balance is supported through hybrid schedules and wellness programs. Career development is prioritized via tuition assistance, online learning platforms, and coaching. Averages tenure is 6.5 years, above industry median, indicating strong employee satisfaction. Smith & Nephew also invests in mental health resources, reflecting a holistic approach to employee well-being.

Job Details & Requirements for this Posting

This position is for a Senior Regulatory Affairs Specialist at Smith & Nephew, located in Memphis, Tennessee (this role may be hybrid). Reporting to the Director of Regulatory Affairs, the specialist will lead global regulatory strategies for orthopaedic and wound care devices.

Responsibilities:

  • Develop and execute regulatory submission plans for FDA (510(k), PMA, De Novo), EU MDR, and international competent authorities.
  • Prepare and review technical documentation, clinical evaluation reports, and labeling compliance.
  • Provide regulatory guidance to cross-functional teams during product development.
  • Monitor global regulatory trends and implement necessary adjustments.
  • Facilitate interactions with notified bodies and regulatory agencies.
  • Mentor junior regulatory staff and coordinate training.

Qualifications:

  • Bachelor’s degree in a life science, engineering, or related field; advanced degree preferred.
  • Minimum 7 years of regulatory affairs experience in medical devices.
  • In-depth knowledge of FDA 21 CFR Part 820/ISO 13485, EU MDR, and regional requirements.
  • Proven track record of successful submissions and approvals.
  • Strong analytical, writing, and communication skills.
  • RAC (Regulatory Affairs Certification) preferred.

Why join Smith & Nephew? Beyond competitive compensation and benefits (including stock purchase plan, 401(k) match, and paid parental leave), this role offers exposure to high-impact products and global markets. Smith & Nephew provides a platform for professional growth through mentoring, tuition reimbursement, and rotational programs. Employees contribute to life-changing innovations and enjoy a company culture that values diversity, innovation, and integrity.

Customer Reviews and Industry Reputation

Smith & Nephew’s reputation is evaluated across multiple platforms, reflecting both employee and customer feedback. Below is an exhaustive analysis.

GLASSDOOR

With over 3,000 reviews, Smith & Nephew holds a 3.8/5 rating. Employees praise the collaborative culture, career advancement opportunities, and strong product portfolio. Common strengths include “great work-life balance,” “innovative products,” and “supportive management.” Criticisms include salary competitiveness (below some peers) and occasional bureaucracy. The CEO approval rating is 72%, indicating overall trust in leadership. Glassdoor rates Smith & Nephew in the top 25% of medtech companies for employee satisfaction.

INDEED

Indeed lists 2,200+ reviews with a 4.0/5 average. Positive mentions focus on “good benefits,” “international exposure,” and “pride in making a difference.” Negative feedback points to “slow decision-making” and “limited remote flexibility” in some roles. Many reviews highlight the company’s commitment to training and safety.

GARTNER PEER INSIGHTS

Though Smith & Nephew is not a pure software provider, it receives reviews on Gartner Peer Insights for its surgical and wound management solutions. Physicians rate its robotic systems highly, with scores averaging 4.5/5 for functionality, ease of use, and support. Users note the CORI system’s intuitive interface and accuracy. Some mention high initial cost but strong ROI in reduced surgery time.

TRUSTPILOT

Trustpilot reviews (mostly from patients) are mixed. The company has a 2.8/5 rating, largely due to product complaints (e.g., wound dressings not adhering well) and customer service responsiveness. However, many positive reviews praise the effectiveness of PICO dressings and recovery after joint replacement using Smith & Nephew implants.

G2

G2 scores are relevant for Smith & Nephew’s digital surgery platforms. The CORI system holds a 4.6/5 rating, lauded for its “seamless integration” and “training support.” Customers recommend it for complex knee cases. A minority report minor software glitches that were quickly resolved.

GOOGLE REVIEWS

Smith & Nephew’s corporate headquarters and manufacturing sites receive 4.1/5 on Google Maps. Employees and visitors value the modern facilities and green initiatives. Complaints are rare but include parking congestion at the Memphis campus.

LINKEDIN REPUTATION

LinkedIn ranks Smith & Nephew in the top 5% of companies globally for employer branding. The company has 400k+ followers. Its content strategy—featuring surgical videos, employee spotlights, and innovation announcements—generates high engagement (2x industry average). LinkedIn ratings from current/former employees show 4.2/5, with comments on “transparent leadership” and “impactful work.”

Why Organizations Choose Smith & Nephew

Hospitals and clinics select Smith & Nephew for proven clinical outcomes, innovation leadership, and comprehensive training. The company’s evidence-based products reduce revision rates and hospital stays. Its educational programs, such as the Smith & Nephew Academy, help surgeons adopt new techniques efficiently. Additionally, the company’s global supply chain reliability and dedicated field support ensure minimal disruption. For group purchasing organizations (GPOs), Smith & Nephew offers competitive pricing and value-added services like inventory management. These factors build long-term trust and partnership.

Official Contact Information

For inquiries and assistance, please reach out to Smith & Nephew using the following contact details:

Address: 1450 Brooks Road, Memphis, TN 38116, USA
Contact Number: +1 901 396 2121
Support Number: +1 800 343 5717
Helpdesk Number: +1 901 399 5000
Website: Smith & Nephew Official Website

Official Social Media Presence

  • LinkedIn: https://www.linkedin.com/company/smith-nephew
  • Twitter/X: https://twitter.com/SmithNephew
  • Facebook: https://www.facebook.com/SmithNephew
  • YouTube: https://www.youtube.com/user/smithnephew
  • Instagram: https://www.instagram.com/smithnephew/

SEO FAQ Section

1. What is the mission of Smith & Nephew?

Smith & Nephew’s mission is to make a meaningful difference in people’s lives by providing innovative medical technologies that enhance patient mobility and healing.

2. Where is Smith & Nephew headquartered?

Smith & Nephew is headquartered in London, United Kingdom, with major operational hubs in Memphis, Tennessee, and Watford, UK.

3. Who is the CEO of Smith & Nephew?

The CEO of Smith & Nephew is Deepak Nath, who assumed the role in 2023.

4. How many employees does Smith & Nephew have?

Smith & Nephew employs over 18,000 people across more than 30 countries.

5. What are the main product segments of Smith & Nephew?

Smith & Nephew’s main segments are Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management.

6. Does Smith & Nephew have robotic surgery products?

Yes, Smith & Nephew offers the CORI Surgical System, a robotic‑assisted platform for knee replacement surgery.

7. Is Smith & Nephew a publicly traded company?

Yes, Smith & Nephew is listed on the New York Stock Exchange (SNN) and the London Stock Exchange (SN).

8. What is Smith & Nephew’s annual revenue?

Smith & Nephew reported revenue of approximately $5.6 billion USD in 2023.

9. How can I apply for a job at Smith & Nephew?

Interested candidates can apply through the careers page at Smith & Nephew’s official website.

10. What training does Smith & Nephew provide to surgeons?

Smith & Nephew operates the Smith & Nephew Academy, offering hands‑on workshops, e‑learning modules, and cadaver‑based training.

11. What is Smith & Nephew’s involvement in sustainability?

Smith & Nephew aims for carbon neutrality by 2045 and has set 2030 interim targets for emissions reduction and waste management.

12. Does Smith & Nephew have a diversity and inclusion program?

Yes, Smith & Nephew has employee resource groups, inclusive hiring practices, and has been recognized on the Human Rights Campaign Corporate Equality Index.

13. What is the PICO system?

PICO is Smith & Nephew’s single‑use negative pressure wound therapy system designed for improved patient mobility and infection management.

14. How does Smith & Nephew ensure product quality?

Smith & Nephew maintains ISO 13485 certification, follows FDA quality regulations, and conducts rigorous internal audits and supplier assessments.

15. What clinical evidence supports Smith & Nephew products?

Smith & Nephew has published hundreds of peer‑reviewed studies and is actively conducting 50+ clinical trials.

16. Can I purchase Smith & Nephew products directly?

No, Smith & Nephew sells through a direct sales force and authorized distributors in each market.

17. What acquisitions has Smith & Nephew made recently?

Recent acquisitions include Blue Belt Technologies (robotics), Osia (wound care), and Plus Orthopedics.

18. Does Smith & Nephew offer internship programs?

Yes, Smith & Nephew has a global internship and graduate program for university students and recent graduates.

19. What is the company culture at Smith & Nephew?

Smith & Nephew promotes a collaborative, inclusive, and innovative culture with strong emphasis on work‑life balance and career development.

20. How does Smith & Nephew support the community?

Through the Smith & Nephew Foundation, employee volunteering, and donations to health education and environmental initiatives.

For organizations seeking to enhance their digital presence through paid guest posting sites and SEO guest posting services, consider exploring professional guest post backlinks and guest post packages pricing. To order guest posting service, visit Order Guest Posting Service. Meanwhile, learn more about Smith & Nephew’s innovations at the official Smith & Nephew website.


Share:

Your experience on this site will be improved by allowing cookies Cookie Policy